1. Home
  2. ABEO vs PSF Comparison

ABEO vs PSF Comparison

Compare ABEO & PSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABEO
  • PSF
  • Stock Information
  • Founded
  • ABEO 1974
  • PSF 2010
  • Country
  • ABEO United States
  • PSF United States
  • Employees
  • ABEO N/A
  • PSF N/A
  • Industry
  • ABEO Biotechnology: Pharmaceutical Preparations
  • PSF Investment Managers
  • Sector
  • ABEO Health Care
  • PSF Finance
  • Exchange
  • ABEO Nasdaq
  • PSF Nasdaq
  • Market Cap
  • ABEO 256.9M
  • PSF 235.2M
  • IPO Year
  • ABEO 1980
  • PSF N/A
  • Fundamental
  • Price
  • ABEO $6.24
  • PSF $19.53
  • Analyst Decision
  • ABEO Strong Buy
  • PSF
  • Analyst Count
  • ABEO 5
  • PSF 0
  • Target Price
  • ABEO $17.80
  • PSF N/A
  • AVG Volume (30 Days)
  • ABEO 1.7M
  • PSF 25.0K
  • Earning Date
  • ABEO 05-15-2025
  • PSF 01-01-0001
  • Dividend Yield
  • ABEO N/A
  • PSF 7.69%
  • EPS Growth
  • ABEO N/A
  • PSF N/A
  • EPS
  • ABEO N/A
  • PSF N/A
  • Revenue
  • ABEO N/A
  • PSF N/A
  • Revenue This Year
  • ABEO N/A
  • PSF N/A
  • Revenue Next Year
  • ABEO $383.07
  • PSF N/A
  • P/E Ratio
  • ABEO N/A
  • PSF N/A
  • Revenue Growth
  • ABEO N/A
  • PSF N/A
  • 52 Week Low
  • ABEO $3.93
  • PSF $16.00
  • 52 Week High
  • ABEO $7.32
  • PSF $20.19
  • Technical
  • Relative Strength Index (RSI)
  • ABEO 56.57
  • PSF 55.16
  • Support Level
  • ABEO $5.93
  • PSF $19.10
  • Resistance Level
  • ABEO $7.17
  • PSF $19.51
  • Average True Range (ATR)
  • ABEO 0.44
  • PSF 0.16
  • MACD
  • ABEO -0.01
  • PSF 0.00
  • Stochastic Oscillator
  • ABEO 50.00
  • PSF 72.88

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

About PSF Cohen & Steers Select Preferred and Income Fund Inc.

Cohen & Steers Select Preferred and Income Fund Inc is a diversified, closed-end investment company. The Fund's primary investment objective is high current income with capital appreciation as its secondary objective. The Fund invests at least of its Managed Assets in preferred and other income securities issued by U.S. and non-U.S. companies.

Share on Social Networks: